Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Goldline Pharmaceutical Ltd (NSE: GLPL), ISIN INE1CLW01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GLPL last traded at ₹32.50 (-1.52%), with a 52-week range of ₹28.50 to ₹60.00 (as of 9 Oct 2026).
EquiSense Score (ECS): 63/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.